This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Biomerieux, Inc.. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: The Innovative Contributions of Roger Luddington
Introduction
Roger Luddington is a notable inventor based in Cambs, GB. He has made significant contributions to the field of coagulation testing through his innovative patent. His work focuses on determining a patient's hemostatic potential, which is crucial for various medical applications.
Latest Patents
Luddington holds a patent for a "Reagent and kit for determining global coagulability and hemostatic potential." This invention provides a method for assessing whether a patient is hypercoagulable, hypocoagulable, or normal. The test involves taking a sample from the patient and initiating coagulation in the presence of an activator. The process monitors the formation of intrinsic tenase-dependent fibrin polymerization over time, allowing for a comprehensive assessment of the patient's coagulation status. This innovative assay can evaluate the hemostatic potential of a sample effectively.
Career Highlights
Throughout his career, Roger Luddington has worked with reputable organizations, including Biomerieux, Inc. and the University of Cambridge. His experience in these institutions has contributed to his expertise in coagulation and hemostatic testing.
Collaborations
Luddington has collaborated with notable colleagues such as Liliana M Tejidor and Timothy J Fischer. These partnerships have likely enhanced his research and development efforts in the field of coagulation.
Conclusion
Roger Luddington's contributions to the field of coagulation testing through his innovative patent demonstrate his commitment to advancing medical science. His work has the potential to significantly impact patient care and treatment outcomes.